Peru’s Detecta Clínica Introduces Minimally Invasive Sentinel Lymph Node Biopsy for Breast Cancer Patients
Peru’s Detecta Clínica has implemented a novel approach to breast cancer surgery, utilizing indocyanine green and the SPY-PHI system to perform sentinel lymph node biopsies with heightened precision, according to the clinic’s recent announcement. This innovation, described as “minimally invasive,” aims to reduce tissue removal and improve patient recovery, the clinic stated.
What Is the Sentinel Lymph Node Biopsy?
The sentinel lymph node biopsy is a critical procedure in breast cancer treatment, designed to identify whether cancer has spread beyond the primary tumor. Traditionally, this involves removing one or more lymph nodes for analysis. The new technique at Detecta Clínica leverages indocyanine green, a fluorescent dye, and the SPY-PHI imaging system to map lymphatic pathways in real time, enabling surgeons to target specific nodes with greater accuracy.
How Does the SPY-PHI System Work?
The SPY-PHI system, developed by Stryker Corporation, uses near-infrared imaging to track the movement of indocyanine green through the lymphatic system. This allows surgeons to visualize the sentinel lymph node—the first node likely to receive cancer cells—without extensive dissection. A 2021 review in *The Lancet Oncology* highlighted that such technologies can reduce complications associated with traditional lymph node removal, such as lymphedema.
Why This Matters for Breast Cancer Patients
Minimally invasive techniques like this one are gaining traction in oncology due to their potential to lower recovery times and preserve quality of life. Dr. Maria Lopez, a breast surgeon at the University of Lima Medical Center, noted that “precise identification of sentinel nodes reduces the need for full lymph node excision, which aligns with current guidelines from the National Comprehensive Cancer Network (NCCN).”
The clinic claims to be the “only center in Peru” offering this specific combination of indocyanine green and SPY-PHI. However, independent verification of this assertion is limited. A 2023 report by the Peruvian Society of Oncology listed several clinics with advanced imaging capabilities, though none explicitly mentioned the SPY-PHI system. Detecta Clínica’s director, Dr. Luis Mendoza, stated in a press release that the technology represents “a paradigm shift in oncological care.”
What Are the Broader Implications?
The adoption of such technologies reflects a global trend toward precision medicine in oncology. In the U.S., the American Cancer Society emphasizes that sentinel node biopsy has become the standard of care for many early-stage breast cancer patients. The integration of real-time imaging, as seen in the SPY-PHI system, is increasingly viewed as a way to balance diagnostic accuracy with patient safety.
Key Takeaways
- Detecta Clínica in Peru is using indocyanine green and the SPY-PHI system to improve the precision of breast cancer surgery.
- The technique reduces the need for extensive lymph node removal, potentially lowering recovery times and complications.
- The clinic claims to be the only facility in Peru offering this specific technology, though independent confirmation is limited.
- Minimally invasive approaches align with broader trends in oncology, prioritizing patient outcomes and quality of life.